Shares of Novavax Inc. NVAX advanced 2.09% to $7.32 Wednesday, on what proved to be an all-around mixed trading session for ...
A recent survey conducted by the HIV Medicine Association identified barriers to implementation of long-acting injectables ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback